Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be a backend/content-management update with no changes to the study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new Locations section showing Seattle, Washington as a study site. Removed the Washington Locations entry and HHS Vulnerability Disclosure footer item; page revision updated to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedA new note states that publications are automatically filled from PubMed and the page now shows revision v3.3.2, replacing the previous wording and revision v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedA site-wide notice about government funding lapse and potential delays has been removed. This notice previously warned that information on the page may not be up to date.SummaryDifference0.4%

- Check74 days agoChange DetectedNo significant changes to core study content (title, objectives, eligibility criteria, endpoints) are detected between screenshots; observed differences appear to be cosmetic or formatting related. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check96 days agoChange DetectedPage updated to version v3.2.0 and now includes a government operations status notice; older version tag v3.1.0 was removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.